Open AccessJournal Article
Vaccination Greatly Reduces Disease, Disability, Death and Inequity worldwide/La Vaccination Reduit Fortement la Morbidite, Les Incapacites, la Mortalite et Les Inegalites Dans L'ensemble Du monde/La Vacunacion Reduce Considerablemente la Morbilidad, Las Discapacidades, la Mortalidad Y Las Inequidades En Todo El Mundo
FE Andre,Robert Booy,Hans L. Bock,John D. Clemens,Sanjoy K Datta,John Tj,Bee Wah Lee,S Lolekha,Heikki Peltola,Tilman A Ruff,M Santosham,Heinz-Josef Schmitt +11 more
Reads0
Chats0
TLDR
In this article, the authors show how vaccines are valuable to both individuals and societies, to present validated facts, and to help redress adverse perceptions of vaccine safety and effectiveness, and the best way in the long term is to refute wrong allegations at the earliest opportunity by providing scientifically valid data This is easier said than done, because the adversary in this game plays according to rules that are not generally those of scienceAbstract:
Introduction Vaccination has greatly reduced the burden of infectious diseases Only clean water, also considered to be a basic human right, performs better (1) Paradoxically, a vociferous antivaccine lobby thrives today in spite of the undeniable success of vaccination programmes against formerly fearsome diseases that are now rare in developed countries (2) Understandably, vaccine safety gets more public attention than vaccination effectiveness, but independent experts and WHO have shown that vaccines are far safer than therapeutic medicines (2,3) Modern research has spurred the development of less reactogenic products, such as acellular pertussis vaccines and rabies vaccines produced in cell culture Today, vaccines have an excellent safety record and most "vaccine scares" have been shown to be false alarms (4,5) Misguided safety concerns in some countries have led to a fall in vaccination coverage, causing the re-emergence of pertussis and measles (6) Putative vaccine safety issues are commonly reported while reviews of vaccine benefits are few A Medline search over the past five years using the keywords "vaccine risks" scored approximately five times as many hits (2655 versus 557) as a Medline search using "vaccine benefits" as keywords (7) This reflects the fact that negative aspects of vaccination get much more publicity than positive aspects How one addresses the antivaccine movement has been a problem since the time of Jenner The best way in the long term is to refute wrong allegations at the earliest opportunity by providing scientifically valid data This is easier said than done, because the adversary in this game plays according to rules that are not generally those of science This issue will not be further addressed in this paper, which aims to show how vaccines are valuable to both individuals and societies, to present validated facts, and to help redress adverse perceptions Without doubt, vaccines are among the most efficient tools for promoting individual and public health and deserve better press (8) Disease control benefits Eradication Unless an environmental reservoir exists, an eradicated pathogen cannot reemerge, unless accidentally or malevolently reintroduced by humans, allowing vaccination or other preventive measures to be discontinued While eradication may be an ideal goal for an immunization programme, to date only smallpox has been eradicated, allowing discontinuation of routine smallpox immunization globally Potentially, other infectious diseases with no extrahuman reservoir can be eradicated provided an effective vaccine and specific diagnostic tests are available Eradication requires high levels of population immunity in all regions of the world over a prolonged period with adequate surveillance in place (9) The next disease targeted for eradication is polio, which is still a global challenge (10) Although high coverage with oral polio vaccine (OPV) has eliminated type 2 poliovirus globally, transmission of types 1 and 3 continues in limited areas in a few countries OPV-caused paralytic disease, directly or by reversion to virulence, and persistent vaccine-virus excretion in immunodeficient individuals are problems yet to be solved Global use of monovalent type 1 and type 30PV and inactivated polio vaccine (IPV) may eventually be required (10) Elimination Diseases can be eliminated locally without global eradication of the causative microorganism In four of six WHO regions, substantial progress has been made in measles elimination; transmission no longer occurs indigenously and importation does not result in sustained spread of the virus (11) Key to this achievement is more than 95% population immunity through a two-dose vaccination regimen Combined measles, mumps and rubella (MMR) vaccine could also eliminate and eventually eradicate rubella and mumps (11) Increasing measles immunization levels in Africa, where coverage averaged only 67% in 2004, is essential for eradication of this disease …read more
Citations
More filters
Vaccine strategies: Optimising outcomes
Karin Hardt,Paolo Bonanni,Susan King,José Ignacio Santos,Mostafa A. El-Hodhod,Gregory D. Zimet,Scott Preiss +6 more
TL;DR: In this article, a review of vaccination implementation strategies reveals differing degrees of success and the factors that encourage success, which often include strong support from government and healthcare organisations, as well as tailored, culturally-appropriate local approaches to optimise outcomes.
DissertationDOI
The knowledge discovery cube framework : a reference framework for collaborative, information-driven pharmacovigilance.
TL;DR: This research proposes a new paradigm for collaborative, information-driven innovation in pharmacovigilance and develops a Reference Framework, in order to deepen the collective understanding of how a principled, collaborative and balanced medicines safety data ecosystem can be organised.
Organizacion social del trabajo en la posmodernidad
Norma González González,Alicia Margarita Tinoco Garcia,Laura Elizabeth Benhumea González,Josefina Amparo Ramirez Velazquez,Brian Martin,Florencia Peña Saint Martin,Rebeca Del Pino Peña,Maria De Los Angeles Garduño Andrade,Ana Lau Jaiven,Paola Beatriz Zenteno Luna,Aristeo Santos López,Silvia Karla Fernandez Marin +11 more
TL;DR: The conjunto derivado del cuerpo academico de la facultad de ciencias politicas de la Universidad de Cárdenas as discussed by the authors.
Posted Content
Besoin d’un rappel? Comment améliorer la couverture vaccinale des enfants au Canada
TL;DR: The many reasons immunization coverage is falling below national targets are explored and the differences in how provinces organize their immunization programs are analyzed, encouraging provinces to share lessons learned and embrace common challenges are analyzed.
References
More filters
Book
Infectious Diseases of Humans: Dynamics and Control
Roy M. Anderson,Robert M. May +1 more
TL;DR: This book discusses the biology of host-microparasite associations, dynamics of acquired immunity heterogeneity within the human community indirectly transmitted helminths, and the ecology and genetics of hosts and parasites.
Journal ArticleDOI
Safety and Efficacy of an Attenuated Vaccine against Severe Rotavirus Gastroenteritis
Guillermo M. Ruiz-Palacios,Irene Pérez-Schael,F. Raúl Velázquez,Hector Abate,Thomas Breuer,Sue Ann Costa Clemens,Brigitte Cheuvart,Felix Espinoza,Paul Gillard,Bruce L. Innis,Yolanda Cervantes,Alexandre da Costa Linhares,Pio Lopez,Mercedes Macias-Parra,Eduardo Ortega-Barria,Vesta Richardson,Doris Maribel Rivera-Medina,Luis Rivera,Belén Salinas,Noris Pavía-Ruz,Jorge Salmerón,Ricardo Rüttimann,Juan Carlos Tinoco,Pilar Rubio,Ernesto Nuñez,M. Lourdes Guerrero,Juan Pablo Yarzabal,Silvia Damaso,Nadia Tornieporth,Xavier Sáez-Llorens,Rodrigo Vergara,Timo Vesikari,Alain Bouckenooghe,Ralf Clemens,Beatrice De Vos,Miguel O'Ryan +35 more
TL;DR: Two oral doses of the live attenuated G1P[8] HRV vaccine were highly efficacious in protecting infants against severe rotavirus gastroenteritis, significantly reduced the rate of severe gastroenteropathy from any cause, and were not associated with an increased risk of intussusception.
Journal ArticleDOI
Sustained efficacy up to 4·5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial
Diane M. Harper,Eduardo L. Franco,Cosette M. Wheeler,Anna-Barbara Moscicki,Barbara Romanowski,Cecilia Roteli-Martins,D. G. Jenkins,Anne Schuind,Sue Ann Costa Clemens,Gary Dubin +9 more
TL;DR: Broad protection against cytohistological outcomes beyond that anticipated for HPV 16/18 and protection against incident infection with HPV 45 and HPV 31 is noted and the vaccine has a good long-term safety profile.
Journal ArticleDOI
Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial
Felicity T. Cutts,Syed M. A. Zaman,Godwin Enwere,Shabbar Jaffar,Orin S. Levine,Orin S. Levine,J. B. Okoko,Claire Oluwalana,Adeola Vaughan,Steven Obaro,Amanda Leach,Keith P. W. J. McAdam,Ekow Biney,Mark Saaka,U. Onwuchekwa,Fred G. Yallop,Nathaniel F. Pierce,Brian Greenwood,Richard A. Adegbola +18 more
TL;DR: Pneumococcal conjugate vaccine has high efficacy against radiological pneumonia and invasive pneumococcal disease, and can substantially reduce admissions and improve child survival in this rural African setting.